A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal

被引:14
|
作者
Pakarinen, P
Luukkainen, T
Elomaa, K
Ratsula, K
Venesmaa, P
Tuominen, J
Lahteenmaki, P
机构
[1] UNIV HELSINKI, INST BIOMED, STEROID RES LAB, SF-00014 HELSINKI, FINLAND
[2] HELSINKI CITY MATERN HOSP, HELSINKI, FINLAND
[3] VAESTOLIITTO FAMILY FEDERAT FINLAND, HELSINKI, FINLAND
[4] UNIV TURKU, FAC MED, DEPT BIOSTAT, TURKU, FINLAND
[5] UNIV HELSINKI, CENT HOSP, DEPT OBSTET & GYNECOL, HELSINKI, FINLAND
关键词
levonorgestrel-releasing intrauterine device; contraception;
D O I
10.1016/S0010-7824(96)00175-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A randomized study was performed in two clinics in order to compare the efficacy safety and acceptability of a new model of a levonorgestrel-releasing intracervical device situated either in the cervical canal (group I) or in the uterine cavity (group II). Group I included 151 women (age 18-43) and group II, 147 women (age 19-43). The number of nulliparous women was 145. The total expulsion rare was 9.1%. The expulsion rate was lower among nulliparous women (4.8%) than among parous woman (13.1%). There was also a significant difference in the expulsion rates between the two clinics. Two pregnancies occurred in both groups and two of these were ectopic, one in each group. The other two occurred after unnoticed expulsion. These figures give 12-month cumulative pregnancy rates of 1.3% and 1.4% in groups I and II, respectively Total infection rate was 0.3%. The continuation rates were 82.1% in group I and 85.0% in group II after the first year. At three-month follow-up there were significantly fewer menstrual problems in group I than in group II (p = 0.0266). It is concluded that expulsion is still a problem with a small device but it may be diminished by intrauterine insertion and by selecting the users carefully. (C) 1996 P. Pakarinen et al.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 7 条
  • [1] Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6-and 12-month morphological and clinical follow-up
    Palmara, Vittorio
    Sturlese, Emanuele
    Villari, Daniela
    Giacobbe, Valentina
    Retto, Annalisa
    Santoro, Giuseppe
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2013, 53 (04): : 381 - 385
  • [2] EFFECTIVE CONTRACEPTION WITH THE LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE - 12-MONTH REPORT OF A EUROPEAN MULTICENTER STUDY
    LUUKKAINEN, T
    ALLONEN, H
    HAUKKAMAA, M
    HOLMA, P
    PYORALA, T
    TERHO, J
    TOIVONEN, J
    BATAR, I
    LAMPE, L
    ANDERSSON, K
    ATTERFELDT, P
    JOHANSSON, DB
    NILSSON, S
    NYGREN, KG
    ODLIND, V
    OLSSON, SE
    RYBO, G
    SIKSTROM, B
    NIELSEN, NC
    BUCH, A
    OSLER, M
    STEIER, A
    ULSTEIN, M
    [J]. CONTRACEPTION, 1987, 36 (02) : 169 - 179
  • [4] PITUITARY AND OVARIAN-FUNCTION AND CLINICAL-PERFORMANCE DURING THE USE OF A LEVONORGESTREL-RELEASING INTRACERVICAL CONTRACEPTIVE DEVICE
    KURUNMAKI, H
    TOIVONEN, J
    LAHTEENMAKI, PLA
    LUUKKAINEN, T
    [J]. CONTRACEPTION, 1984, 29 (01) : 31 - 43
  • [6] Clinical performance of the levonorgestrel intra-uterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 12-month report
    Cox, M
    Blacksell, S
    [J]. BRITISH JOURNAL OF FAMILY PLANNING, 2000, 26 (03): : 143 - 147
  • [7] A 12-MONTH COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING 20-MU-G ETHINYLESTRADIOL 75-MU-G CESTODENE AND 20-MU-G ETHINYLESTRADIOL 75-MU-G DESOGESTREL, WITH RESPECT TO EFFICACY, CYCLE CONTROL AND TOLERANCE
    ENDRIKAT, J
    JAQUES, MA
    MAYERHOFER, M
    PELISSIER, C
    MULLER, U
    DUSTERBERG, B
    [J]. CONTRACEPTION, 1995, 52 (04) : 229 - 235